Cargando…

Hypovitaminosis D in HIV-infected patients in Lisbon: a link with antiretroviral treatment

INTRODUCTION: Recent data indicates that low vitamin D (25(OH)D) levels can lead to a worst prognosis in HIV-infected individuals, even in those on successful antiretroviral therapy (ART) [1]. Portugal is the European country that has the largest average sun exposure time but prevalence of hypovitam...

Descripción completa

Detalles Bibliográficos
Autores principales: Boura, Márcia, Filipa Sutre, Ana, Badura, Robert, Zagalo, Alexandra, Afonso, Cláudia, Caldeira, Luís, Valadas, Emília
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225260/
https://www.ncbi.nlm.nih.gov/pubmed/25397570
http://dx.doi.org/10.7448/IAS.17.4.19826
_version_ 1782343473163141120
author Boura, Márcia
Filipa Sutre, Ana
Badura, Robert
Zagalo, Alexandra
Afonso, Cláudia
Caldeira, Luís
Valadas, Emília
author_facet Boura, Márcia
Filipa Sutre, Ana
Badura, Robert
Zagalo, Alexandra
Afonso, Cláudia
Caldeira, Luís
Valadas, Emília
author_sort Boura, Márcia
collection PubMed
description INTRODUCTION: Recent data indicates that low vitamin D (25(OH)D) levels can lead to a worst prognosis in HIV-infected individuals, even in those on successful antiretroviral therapy (ART) [1]. Portugal is the European country that has the largest average sun exposure time but prevalence of hypovitaminosis D is mostly unknown. Our aim was to determine the prevalence of hypovitaminosis D in HIV patients in Lisbon and the possible association with ART. METHODS: From 2012 to January 2014, plasma samples from 518 HIV-infected patients were collected to 25(OH)D levels determination. Data on demographic features (age, ethnicity, country of origin) and clinical/laboratory parameters were collected from clinical files (HIV subtype, CD4+ cell count, CD4+ nadir, viral load (VL), HBV/HCV co-infection and ART). 25(OH)D status was defined as: deficiency <20 ng/mL, insufficiency 20–30 ng/mL, optimal >30 ng/mL. RESULTS: Median age was 46 years old (±11); 62.0% (321/518) were male; 81.3% (421/518) were Caucasian and 78.6% (407/518) were Portuguese. Most patients (96.1%; 498/518), were HIV-1 infected, 22.9% (114/498) and 4.0% (20/498) of them were HCV and/or HBV co-infected, respectively. Mean CD4+ cell count was 648 cells/µL (±333) and nadir was 219 cells/µL (±179). On treated patients VL was <40 HIV RNA/mL in 86.7% (417/481). The median levels of 25(OH)D was 20.0 ng/mL (range 4.1–99.7) and we found differences between values observed during Winter (median 16.7 ng/mL) and Summer (median 24.9 ng/mL) (p<0.0001). Low 25(OH)D levels were not correlated to ethnicity (p=0.066). 25(OH)D level was <30 ng/mL in 80.1% (415/518) of the patients, from which 30.9% (160/518) and 49.2% (255/518) had insufficiency and deficiency levels, respectively. Most (92.9%; 481/518) were on ART: regimens containing PI (47.5%), NNRTI (40.3%; 41.3% on NVP and 58.7% on EFV), II (1.2%), PI+NNRTI (3.9%). Comparing the 25(OH)D level along the different ART regimens (PI vs NVP; PI vs EFV; PI vs no ART) there were differences between PI and EFV (p=0.044). CONCLUSIONS: In this study, 80.1% of the HIV-infected patients had hypovitaminosis D and ART regimens with EFV were more often associated with low 25(OH)D levels. Understanding the impact of the different antiretroviral drugs on 25(OH)D status could help to decide in clinical practice whether 25(OH)D supplementation or drug switch are the best options for each patient.
format Online
Article
Text
id pubmed-4225260
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher International AIDS Society
record_format MEDLINE/PubMed
spelling pubmed-42252602014-11-12 Hypovitaminosis D in HIV-infected patients in Lisbon: a link with antiretroviral treatment Boura, Márcia Filipa Sutre, Ana Badura, Robert Zagalo, Alexandra Afonso, Cláudia Caldeira, Luís Valadas, Emília J Int AIDS Soc Poster Sessions – Abstract P294 INTRODUCTION: Recent data indicates that low vitamin D (25(OH)D) levels can lead to a worst prognosis in HIV-infected individuals, even in those on successful antiretroviral therapy (ART) [1]. Portugal is the European country that has the largest average sun exposure time but prevalence of hypovitaminosis D is mostly unknown. Our aim was to determine the prevalence of hypovitaminosis D in HIV patients in Lisbon and the possible association with ART. METHODS: From 2012 to January 2014, plasma samples from 518 HIV-infected patients were collected to 25(OH)D levels determination. Data on demographic features (age, ethnicity, country of origin) and clinical/laboratory parameters were collected from clinical files (HIV subtype, CD4+ cell count, CD4+ nadir, viral load (VL), HBV/HCV co-infection and ART). 25(OH)D status was defined as: deficiency <20 ng/mL, insufficiency 20–30 ng/mL, optimal >30 ng/mL. RESULTS: Median age was 46 years old (±11); 62.0% (321/518) were male; 81.3% (421/518) were Caucasian and 78.6% (407/518) were Portuguese. Most patients (96.1%; 498/518), were HIV-1 infected, 22.9% (114/498) and 4.0% (20/498) of them were HCV and/or HBV co-infected, respectively. Mean CD4+ cell count was 648 cells/µL (±333) and nadir was 219 cells/µL (±179). On treated patients VL was <40 HIV RNA/mL in 86.7% (417/481). The median levels of 25(OH)D was 20.0 ng/mL (range 4.1–99.7) and we found differences between values observed during Winter (median 16.7 ng/mL) and Summer (median 24.9 ng/mL) (p<0.0001). Low 25(OH)D levels were not correlated to ethnicity (p=0.066). 25(OH)D level was <30 ng/mL in 80.1% (415/518) of the patients, from which 30.9% (160/518) and 49.2% (255/518) had insufficiency and deficiency levels, respectively. Most (92.9%; 481/518) were on ART: regimens containing PI (47.5%), NNRTI (40.3%; 41.3% on NVP and 58.7% on EFV), II (1.2%), PI+NNRTI (3.9%). Comparing the 25(OH)D level along the different ART regimens (PI vs NVP; PI vs EFV; PI vs no ART) there were differences between PI and EFV (p=0.044). CONCLUSIONS: In this study, 80.1% of the HIV-infected patients had hypovitaminosis D and ART regimens with EFV were more often associated with low 25(OH)D levels. Understanding the impact of the different antiretroviral drugs on 25(OH)D status could help to decide in clinical practice whether 25(OH)D supplementation or drug switch are the best options for each patient. International AIDS Society 2014-11-02 /pmc/articles/PMC4225260/ /pubmed/25397570 http://dx.doi.org/10.7448/IAS.17.4.19826 Text en © 2014 Boura M et al; licensee International AIDS Society http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Sessions – Abstract P294
Boura, Márcia
Filipa Sutre, Ana
Badura, Robert
Zagalo, Alexandra
Afonso, Cláudia
Caldeira, Luís
Valadas, Emília
Hypovitaminosis D in HIV-infected patients in Lisbon: a link with antiretroviral treatment
title Hypovitaminosis D in HIV-infected patients in Lisbon: a link with antiretroviral treatment
title_full Hypovitaminosis D in HIV-infected patients in Lisbon: a link with antiretroviral treatment
title_fullStr Hypovitaminosis D in HIV-infected patients in Lisbon: a link with antiretroviral treatment
title_full_unstemmed Hypovitaminosis D in HIV-infected patients in Lisbon: a link with antiretroviral treatment
title_short Hypovitaminosis D in HIV-infected patients in Lisbon: a link with antiretroviral treatment
title_sort hypovitaminosis d in hiv-infected patients in lisbon: a link with antiretroviral treatment
topic Poster Sessions – Abstract P294
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225260/
https://www.ncbi.nlm.nih.gov/pubmed/25397570
http://dx.doi.org/10.7448/IAS.17.4.19826
work_keys_str_mv AT bouramarcia hypovitaminosisdinhivinfectedpatientsinlisbonalinkwithantiretroviraltreatment
AT filipasutreana hypovitaminosisdinhivinfectedpatientsinlisbonalinkwithantiretroviraltreatment
AT badurarobert hypovitaminosisdinhivinfectedpatientsinlisbonalinkwithantiretroviraltreatment
AT zagaloalexandra hypovitaminosisdinhivinfectedpatientsinlisbonalinkwithantiretroviraltreatment
AT afonsoclaudia hypovitaminosisdinhivinfectedpatientsinlisbonalinkwithantiretroviraltreatment
AT caldeiraluis hypovitaminosisdinhivinfectedpatientsinlisbonalinkwithantiretroviraltreatment
AT valadasemilia hypovitaminosisdinhivinfectedpatientsinlisbonalinkwithantiretroviraltreatment